Abstract
An anti-Gc antiserum (anti-Gc) was prepared by immunizing rabbits with purified Gc, a major vitamin D-binding protein in human serum. Gc is expressed on the surfaces of a small proportion of resting T cells and almost all B cells are natural killer (NK) cells. We investigated the effects of anti-Gc on NK activity of normal peripheral blood lymphocytes. Both anti-Gc and purified IgG isolated from anti-Gc prominently inhibited human NK activity in vitro. Inhibition of anti-Gc was dependent on the concentration of the antiserum employed. Competition assay showed that purified Gc significantly blocked the inhibitory effect of anti-Gc. The inhibition of NK activity in the cells treated with anti-Gc was restored time-dependently by being cultured in anti-Gc free medium. Anti-Gc-treated NK cells retained their capacity to bind to target cells. These findings suggest that mGc is associated with the process of the NK cytolysis on the post-binding cytolytic phase.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abe E., Miyaura C., Sakagami H., Takeda M., Konno K., Yamazaki T., Yoshiki S., Suda T. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4990–4994. doi: 10.1073/pnas.78.8.4990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Amino N., Mori H., Iwatani Y., Asari S., Izumiguchi Y., Miyai K. Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves' disease and increase in Hashimoto's disease. J Clin Endocrinol Metab. 1982 Mar;54(3):587–591. doi: 10.1210/jcem-54-3-587. [DOI] [PubMed] [Google Scholar]
- Bhalla A. K., Amento E. P., Clemens T. L., Holick M. F., Krane S. M. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983 Dec;57(6):1308–1310. doi: 10.1210/jcem-57-6-1308. [DOI] [PubMed] [Google Scholar]
- Brunner K. T., Mauel J., Cerottini J. C., Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology. 1968 Feb;14(2):181–196. [PMC free article] [PubMed] [Google Scholar]
- Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem. 1982 Jul 10;257(13):7847–7851. [PubMed] [Google Scholar]
- Daiger S. P., Schanfield M. S., Cavalli-Sforza L. L. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2076–2080. doi: 10.1073/pnas.72.6.2076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haddad J. G. Human serum binding protein for vitamin D and its metabolites (DBP): evidence that actin is the DBP binding component in human skeletal muscle. Arch Biochem Biophys. 1982 Feb;213(2):538–544. doi: 10.1016/0003-9861(82)90581-1. [DOI] [PubMed] [Google Scholar]
- Hiserodt J. C., Britvan L. J., Targan S. R. Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: resolution into binding, programming, and killer cell-independent steps. J Immunol. 1982 Oct;129(4):1782–1787. [PubMed] [Google Scholar]
- Hiserodt J. C., Laybourn K. A., Varani J. Expression of a laminin-like substance on the surface of murine natural killer (NK) lymphocytes and its role in NK recognition of tumor target cells. J Immunol. 1985 Aug;135(2):1484–1487. [PubMed] [Google Scholar]
- Jensen J. R., Jørgensen A. S., Thestrup-Pedersen K. Depression of natural killer cell activity by syphilitic serum and immune complexes. Br J Vener Dis. 1982 Oct;58(5):298–301. doi: 10.1136/sti.58.5.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kiessling R., Wigzell H. An analysis of the murine NK cell as to structure, function and biological relevance. Immunol Rev. 1979;44:165–208. doi: 10.1111/j.1600-065x.1979.tb00270.x. [DOI] [PubMed] [Google Scholar]
- Kimura H., Saheki S., Yoshida K., Ohsawa M. Characterization of purified group-specific components (Gc 1 and Gc 2 proteins) from human plasma. Nihon Hoigaku Zasshi. 1985 Apr;39(2):113–123. [PubMed] [Google Scholar]
- Lanier L. L., Le A. M., Phillips J. H., Warner N. L., Babcock G. F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol. 1983 Oct;131(4):1789–1796. [PubMed] [Google Scholar]
- Lozzio C. B., Lozzio B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975 Mar;45(3):321–334. [PubMed] [Google Scholar]
- Machii T., Kimura H., Ueda E., Chujo T., Morita T., Katagiri S., Tagawa S., Kitani T. Distribution of Gc protein (vitamin D binding protein) on the surfaces of normal human lymphocytes and leukemic lymphocytes. Acta Haematol. 1986;75(1):26–29. doi: 10.1159/000206075. [DOI] [PubMed] [Google Scholar]
- Minowada J., Onuma T., Moore G. E. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst. 1972 Sep;49(3):891–895. [PubMed] [Google Scholar]
- Miyaura C., Abe E., Kuribayashi T., Tanaka H., Konno K., Nishii Y., Suda T. 1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 1981 Oct 15;102(3):937–943. doi: 10.1016/0006-291x(81)91628-4. [DOI] [PubMed] [Google Scholar]
- Petrini M., Emerson D. L., Galbraith R. M. Linkage between surface immunoglobulin and cytoskeleton of B lymphocytes may involve Gc protein. Nature. 1983 Nov 3;306(5938):73–74. doi: 10.1038/306073a0. [DOI] [PubMed] [Google Scholar]
- Petrini M., Galbraith R. M., Werner P. A., Emerson D. L., Arnaud P. Gc (vitamin D binding protein) binds to cytoplasm of all human lymphocytes and is expressed on B-cell membranes. Clin Immunol Immunopathol. 1984 May;31(2):282–295. doi: 10.1016/0090-1229(84)90248-4. [DOI] [PubMed] [Google Scholar]
- Reitsma P. H., Rothberg P. G., Astrin S. M., Trial J., Bar-Shavit Z., Hall A., Teitelbaum S. L., Kahn A. J. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature. 1983 Dec 1;306(5942):492–494. doi: 10.1038/306492a0. [DOI] [PubMed] [Google Scholar]
- Roder J. C., Kiessling R., Biberfeld P., Andersson B. Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing. J Immunol. 1978 Dec;121(6):2509–2517. [PubMed] [Google Scholar]
- Roder J. C., Klein M. Target-effector interaction in the natural killer cell system. IV. Modulation by cyclic nucleotides. J Immunol. 1979 Dec;123(6):2785–2790. [PubMed] [Google Scholar]
- Shinomiya K., Shinomiya T., Yoshida K., Kimura H. Conversion of a plasma group-specific component (vitamin D binding protein) to a macromolecule by a protein factor in tissue extracts. J Biochem. 1982 Oct;92(4):1163–1171. doi: 10.1093/oxfordjournals.jbchem.a134032. [DOI] [PubMed] [Google Scholar]
- Tsai H. C., Norman A. W. Studies on calciferol metabolism. 8. Evidence for a cytoplasmic receptor for 1,25-dihydroxy-vitamin D3 in the intestinal mucosa. J Biol Chem. 1973 Sep 10;248(17):5967–5975. [PubMed] [Google Scholar]
- Tsoukas C. D., Provvedini D. M., Manolagas S. C. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science. 1984 Jun 29;224(4656):1438–1440. doi: 10.1126/science.6427926. [DOI] [PubMed] [Google Scholar]
- Van Baelen H., Bouillon R., De Moor P. Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem. 1980 Mar 25;255(6):2270–2272. [PubMed] [Google Scholar]
- Woda B. A., Woodin M. B. The interaction of lymphocyte membrane proteins with the lymphocyte cytoskeletal matrix. J Immunol. 1984 Nov;133(5):2767–2772. [PubMed] [Google Scholar]
